Avinger Has Received A Notice Of Allowance For Its U.S. Patent Application 17/449,867 Titled "Occlusion-Crossing Devices, Imaging, And Atherectomy Devices"
Portfolio Pulse from Benzinga Newsdesk
Avinger has received a notice of allowance for its U.S. patent application 17/449,867 titled 'Occlusion-Crossing Devices, Imaging, and Atherectomy Devices'.
October 05, 2023 | 6:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avinger's new patent allowance could potentially strengthen its product portfolio and competitive position in the market.
The allowance of a new patent for Avinger signifies the potential introduction of new products or enhancement of existing ones. This could strengthen Avinger's competitive position in the market, potentially leading to increased revenues and a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100